A molecular diagnostic company’s journey from science to product - Providing the answer to the fundamental question - “What type of cancer is it?”-Deborah Neff-02/09/2010 - 6:00pm

Event Information
Event Topic: 
A molecular diagnostic company’s journey from science to product - Providing the answer to the fundamental question - “What type of cancer is it?”
Event Date: 
02/09/2010 - 6:00pm
Event Location: 
TIPS, 1000 Elwell Ct., Palo Alto, CA
Speaker Information
Event Speaker: 
Deborah Neff
Event Speaker Title: 
President and CEO
Event Speaker Company: 
Pathwork Diagnostics, Inc.
Event Speaker Bio: 

Deborah Neff is the President and Chief Executive Officer, and serves on the board of directors, of Pathwork Diagnostics Inc., a company commercializing innovative molecular diagnostic tests focused in oncology. She is a veteran of the life sciences industry, with a proven track record of commercializing successful new products and building market-leading global businesses.

Deborah was previously the chief executive officer of Predicant Biosciences, founded to develop technology for use in proteomics based clinical testing. Prior to joining Predicant in 2003, Deborah served as president of BD Biosciences, (a business segment of Becton Dickinson), where she’d held a series of roles with increasing responsibilities during her 15 years at BD.

As President of BD Biosciences, she led a high growth business that developed and sold biomedical research and clinical diagnostic products worldwide, with revenues of approximately $700 million in 2003. Prior to her tenure at BD, she held various management positions at Organon-Teknika Corp. and CooperBiomedical Inc. Her career began with technical and supervisory roles in the clinical laboratory at two major medical centers in southern California.

Deborah has a BS in Physiology from UC Davis, and is a medical technologist with a specialty in blood banking, having completed graduate study in Immunohematology. She also attended executive business programs in finance, marketing and general management at Wharton, Stanford and Harvard Business Schools.

She served on the board of Advanced Medical Optics Inc, and ForteBio, and is a member of the Dean’s leadership council for the College of Biological Sciences at UC Davis.

Event Details
$6 - Students/In-transition - Members only
$11 - Early-bird Registration - Members only
$20 - Late Registration and Non-Members
$25 - Walk-ins
Event Details: 

Molecular diagnostic approaches, when developed using robust scientific methods and clinical studies, are emerging to provide valuable clinical information for physicians managing and treating patients with cancer. Deborah will share the challenges and successes of Pathwork Diagnostics along their path from science to product to commercialization, bringing an innovative new product to market that has real impact on improving patient care.

Payment Options Dec 12th Evening Event

Attention B2DG members: You must login to your account first to see the members' early-bird admission rate.
If you are not a B2DG member or if you had missed the early-bird deadline, the registration fee is $20. Please follow these instructions to register.

We use PAYPAL to process your online payment. Print and bring a copy of your online receipt with you. If space permits, walk-ins are welcomed; please be prepared to pay $25 at the door (cash or check). There is no refund, exchange, or transfer. Thank you for your cooperation.
To register now, please select your meal preference from the pull-down menu below and enter the attendee's information. Then click on the "Pay Now" button to reach the PayPal payment page. Each attendee must be registered separately.
Make sure you enter the attendee's meal choice, name, and email address.

Meal Choice
Name of Attendee
Email Address